300 Participants Needed

Behavioral Treatment for Emotional Disturbance

PA
KE
KG
Overseen ByKatherine Grimes, Md, MPH
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Cambridge Health Alliance
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment Behavioral Treatment for emotional disturbance?

Research shows that behavioral treatments can effectively change targeted behaviors in psychiatric patients and improve their overall functioning. For example, a study on chronic male psychiatric inpatients found that behavior modification techniques were successful in changing inappropriate behaviors and that these positive effects lasted for 6-12 months after treatment.12345

Is behavioral treatment for emotional disturbance safe for humans?

The safety of behavioral treatments can vary depending on the specific methods used. Some treatments, like physical restraints, may cause injuries or psychological trauma, while medications like ketamine and droperidol have been studied for safety in emergency settings for severe behavioral disturbances.678910

How does the Behavioral Treatment for Emotional Disturbance differ from other treatments?

The Behavioral Treatment for Emotional Disturbance is unique because it involves training occupational therapists to deliver specific behavioral techniques during therapy sessions, ensuring consistent and accurate treatment. This approach is interdisciplinary and focuses on regular, structured sessions, which may not be a feature of other treatments for emotional disturbances.311121314

What is the purpose of this trial?

The Family Connections study, is intended to disrupt disparities in mental health treatment access for children at-risk for childhood trauma (ACEs) and/or serious emotional disturbance (SED). "Family Connections" will use mobile clinical and family support teams to improve mental health outcomes. This clinical innovation, nested in an integrated system-of-care will be piloted for children, ages 3-18 yrs., with SED who receive primary care through Cambridge Health Alliance.

Research Team

KE

Katherine E Grimes, MD, MPH

Principal Investigator

Cambridge Health Alliance

Eligibility Criteria

The Family Connections trial is for children aged 3-18 with potential mental health or substance use issues, identified by primary care physicians at CHA sites. Participants must have a positive mental health screen or parental/PCP concern and be enrolled in MassHealth. It's not suitable for those outside this age range or care network.

Inclusion Criteria

I am between 3 and 17.5 years old.
My primary care doctor from a CHA site referred me for a child mental health or substance use assessment.
I or my child screened positive for mental health/substance use, or there's concern from a parent or doctor.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Family Connections intervention using mobile clinical and family support teams

6 months
Regular visits as part of the intervention

Follow-up

Participants are monitored for changes in clinical functioning and family perceptions of care

6 months
Follow-up assessments at 6 months and 12 months

Treatment Details

Interventions

  • Behavioral Treatment
Trial Overview This study tests a mobile clinical and family support team approach to improve mental health outcomes for at-risk children with serious emotional disturbances (SED). The intervention includes integrated systems of care provided by the Cambridge Health Alliance.
Participant Groups
2Treatment groups
Active Control
Group I: Treatment as UsualActive Control1 Intervention
Group II: Active Comparator: Family Connections InterventionActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Cambridge Health Alliance

Lead Sponsor

Trials
65
Recruited
22,400+

Findings from Research

Behavioral consultation for psychiatric inpatients has been shown to effectively change targeted behaviors, but its impact on recidivism and overall patient functioning is less clear.
In a study involving 7 patients, behavioral consultation was associated with changes in hospital admission frequency and duration, as well as improvements in patients' functioning, suggesting potential benefits beyond immediate behavior modification.
Behavioral consultation with difficult to treat psychiatric patients.Mori, DL., Blake, DD.[2019]
In a study of 141 adults with intellectual disabilities and behavioral disorders, significant improvement in behavioral problems was observed at six months, particularly for those with anxiety disorders, indicating the effectiveness of psychiatric and behavioral treatments.
Patients with more visible behavioral symptoms were more likely to receive behavioral support, while those with less overt symptoms were referred for counseling, suggesting a tailored approach to treatment based on symptom presentation.
Toward impacting medical and psychiatric comorbidities in persons with intellectual/developmental disabilities: an initial prospective analysis.Gentile, JP., Gillig, PM., Stinson, K., et al.[2020]
An innovative interdisciplinary behavioral treatment protocol for depression was developed, where occupational therapists were trained to implement specific behavioral techniques during therapy sessions.
Early results suggest that this treatment can be delivered reliably and accurately, potentially improving functional independence for individuals with depression.
An interdisciplinary behavioral treatment program for depressed geriatric rehabilitation inpatients.Lichtenberg, PA., Kimbarow, ML., MacKinnon, D., et al.[2019]

References

Behavioral consultation with difficult to treat psychiatric patients. [2019]
Toward impacting medical and psychiatric comorbidities in persons with intellectual/developmental disabilities: an initial prospective analysis. [2020]
An interdisciplinary behavioral treatment program for depressed geriatric rehabilitation inpatients. [2019]
Evaluation of long-term therapeutic efficacy of behavior modification program with chronic male psychiatric inpatients. [2019]
Adverse effects of poor behavior management of an inpatient's difficult behaviors. [2019]
Ketamine as Rescue Treatment for Difficult-to-Sedate Severe Acute Behavioral Disturbance in the Emergency Department. [2022]
Management of behavioral emergencies. [2005]
Structured team approach to the agitated patient in the emergency department. [2022]
Parenteral sedation of elderly patients with acute behavioral disturbance in the ED. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Experiences of Individuals Who Were Physically Restrained in the Emergency Department. [2020]
11.United Statespubmed.ncbi.nlm.nih.gov
The effect of a self-management training package on the transfer of aggression control procedures in the absence of supervision. [2019]
12.United Statespubmed.ncbi.nlm.nih.gov
The counseling role of the child and youth worker in a treatment classroom. [2004]
13.United Statespubmed.ncbi.nlm.nih.gov
Evidence-based treatment research: Advances, limitations, and next steps. [2022]
14.United Statespubmed.ncbi.nlm.nih.gov
Effects of an interdependent group contingency on the transition behavior of middle school students with emotional and behavioral disorders. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security